Xylo Technologies (XYLO)

• Market cap: $6.35M
• 1 day: -0.60%
• 5 days: 5.08%
• 1 month: -1.78%
• 3 months: -4.43%
• 6 months: 37.78%
• Year to date: 34.42%
• 1 year: 1.64%
• 5 years: -93.67%
• 10 years: -99.93%
• Sector: Healthcare
• Industry: Medical Devices

About: Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in four segments are: Corporate, Online advertising & internet traffic routing, Online event management, real-estate and electronics. The company's geographical segments include USA, Europe, Great Britain, Israel, Canada, Asia and others.

Employees: 38

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

0.07% less ownership

Funds ownership: 0.2% [Q4 2024] → 0.14% (-0.07%) [Q1 2025]

9% less capital invested

Capital invested by funds: $211K [Q4 2024] → $191K (-$19.7K) [Q1 2025]

25% less funds holding

Funds holding: 8 [Q4 2024] → 6 (-2) [Q1 2025]

50% less funds holding in top 10

Funds holding in top 10: 2 [Q4 2024] → 1 (-1) [Q1 2025]

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1